Pharmafile Logo

Souvenaid

- PMLiVE

Eli Lilly/AbCellera’s COVID-19 variant-targeting antibody enters clinical trials

Drug will be evaluted alone and together with other monoclonal antibodies in the expanded BLAZE-4 trial

- PMLiVE

Pfizer pauses enrolment for trial evaluating anti-BCMA bispecific antibody

Trial pause follows reports of three cases of peripheral neuropathy in phase 1 study

- PMLiVE

BioNTech on course to produce three billion doses of Pfizer-partnered COVID-19 vaccine in 2021

BioNTech’s CEO Ugur Sahin said increase in manufacturing will allow for this target to be met

- PMLiVE

5 ways that lockdowns and restrictions could be affecting our allergies

Over this last year, lockdowns and restrictions have led to changes in the day-to-day environments for people across the world. For Allergy Awareness week, we wanted to explore some of...

IGNIFI

- PMLiVE

Pfizer’s COVID-19 vaccine yields $3.5bn in first quarter sales

Full-year guidance for BioNTech-partnered vaccine increased to $26bn

Top 10 Tips to Increase Engagement During Virtual Events

Natalie Yeadon shares her top tips for making your virtual events engaging and interactive

Impetus Digital

- PMLiVE

FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox

Iron-chelating agent approved for the treatment of transfusional iron overload due to SCD or other anaemias

- PMLiVE

The new reality of building a corporate brand in pharma

The global pandemic has heightened everyone’s awareness of healthcare

- PMLiVE

Novavax is close to finalising a COVID-19 vaccine supply deal with the EU

Reuters reported that the company is planning to send doses to Europe before the end of the year

- PMLiVE

Moderna agrees to supply Gavi with 500 million doses for COVAX

Moderna will deliver an initial 34 million doses to COVAX in the fourth quarter of 2021

Leaders leading leaders: objectivity and respecting the micro-leader

Passionate leaders go far. But clip their wings, fail to recognise their skills or respect their passions, and you’re set for uproar. Especially with Gen Z now established in the...

Fox&Cat

- PMLiVE

Total COVID-19 vaccine spending to reach $157bn by 2025, says report

Report also forecasts total global medicines spending to hit approximately $1.6 trillion in 2025

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links